A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells
Senhaji Mouhri, Zhor, Goodfellow, Elliot, Jean-Claude, BertrandVolume:
17
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-017-3504-1
Date:
December, 2017
File:
PDF, 1.15 MB
english, 2017